Jasjit Singh
Overview
Explore the profile of Jasjit Singh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
324
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mishra K, Kumar S, Jandial A, Sahu K, Sandal R, Ahuja A, et al.
Indian J Hematol Blood Transfus
. 2021 Jul;
37(3):404-413.
PMID: 34267459
Immune thrombocytopenia (ITP) is a relapsing-remitting disease often requiring more than one line of therapy. Rituximab is a recommended second-line therapy, but the real-world data on its efficacy and safety...
12.
Singh J, ODonnell K, Nieves D, Adler-Shohet F, Arrieta A, Ashouri N, et al.
Open Forum Infect Dis
. 2021 Jun;
8(6):ofab165.
PMID: 34113683
Background: species, specifically and (MABs), are known to contaminate water systems and are uncommon causes of health care-associated infection, but morbidity can be significant and treatment complex. Methods: Odontogenic MAB...
13.
Yanamandra U, Sharma R, Shankar S, Yadav S, Kapoor R, Pramanik S, et al.
JCO Glob Oncol
. 2021 May;
7:704-715.
PMID: 33999651
Purpose: The outcomes of patients with myeloma from developing countries are often lacking because of poor record maintenance. Publications from such settings are also limited because of the retrospective nature...
14.
Arrieta A, Galvis A, Morphew T, Ehwerhemuepha L, Osborne S, Enriquez C, et al.
Pediatr Infect Dis J
. 2021 May;
40(7):606-611.
PMID: 33967228
Background: Therapies against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its life-threatening respiratory infection coronavirus disease 2019 (COVID-19) have been evaluated, including COVID-19 convalescent plasma (CCP). Multiple large reports of...
15.
Cooper D, Afghani B, Byington C, Cunningham C, Golub S, Lu K, et al.
Pediatr Res
. 2021 Feb;
90(5):966-970.
PMID: 33627824
As the nation implements SARS-CoV-2 vaccination in adults at an unprecedented scale, it is now essential to focus on the prospect of SARS-CoV-2 vaccinations in pediatric populations. To date, no...
16.
Buchbinder D, Walter J, Butte M, Chan W, Chitty Lopez M, Dimitriades V, et al.
J Clin Immunol
. 2021 Jan;
41(2):294-302.
PMID: 33411155
Newborn screening efforts focusing on the quantification of T cell receptor excision circles (TRECs), as a biomarker for abnormal thymic production of T cells, have allowed for the identification and...
17.
Mishra K, Pramanik S, Jandial A, Sahu K, Sandal R, Ahuja A, et al.
Am J Blood Res
. 2020 Nov;
10(5):240-251.
PMID: 33224568
Immune thrombocytopenia (ITP) is characterized by decreased platelet count in the peripheral circulation. The first-line therapy is corticosteroids with 53-80% overall response rate. Eltrombopag has been used as second-line therapy...
18.
Srivastava S, Kumari B, Garg I, Rai C, Kumar V, Yanamandra U, et al.
Blood Cells Mol Dis
. 2020 Mar;
82:102421.
PMID: 32171843
Venous thrombo-embolism (VTE) is multi-factorial disease involving several genetic and acquired risk factors responsible for its onset. It may occur spontaneously upon climbing at High Altitude (HA). Several studies demonstrated...
19.
Mueller M, Kanack M, Singh J, Jaffurs D, Vyas R
J Craniofac Surg
. 2019 Dec;
31(1):274-277.
PMID: 31794447
In 2016, water lines at a children's dental clinic in Orange County, California were contaminated with Mycobacterium abscessus (MA), a non-tuberculosis rapidly-growing mycobacterium, leading to the largest MA outbreak ever...
20.